Public Employees Retirement System of Ohio Has $6.97 Million Stake in Humana Inc. $HUM

Public Employees Retirement System of Ohio lowered its stake in Humana Inc. (NYSE:HUM) by 3.9% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 40,218 shares of the insurance provider’s stock after selling 1,648 shares during the quarter. Public Employees Retirement System of Ohio’s holdings in Humana were worth $6,973,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in HUM. Aberdeen Group plc lifted its stake in Humana by 18.1% in the 4th quarter. Aberdeen Group plc now owns 283,778 shares of the insurance provider’s stock valued at $72,684,000 after purchasing an additional 43,442 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in shares of Humana by 4.1% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider’s stock worth $66,207,000 after buying an additional 9,960 shares during the last quarter. Ninety One UK Ltd grew its stake in shares of Humana by 57.2% during the fourth quarter. Ninety One UK Ltd now owns 112,501 shares of the insurance provider’s stock worth $28,815,000 after buying an additional 40,958 shares during the last quarter. Sustainable Insight Capital Management LLC increased its holdings in shares of Humana by 23.7% during the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider’s stock worth $6,341,000 after buying an additional 4,740 shares in the last quarter. Finally, Swedbank AB increased its holdings in shares of Humana by 6.2% during the fourth quarter. Swedbank AB now owns 111,803 shares of the insurance provider’s stock worth $28,636,000 after buying an additional 6,534 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Guggenheim raised their price objective on Humana from $252.00 to $269.00 and gave the company a “buy” rating in a report on Thursday, April 30th. Leerink Partners boosted their price objective on Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a research report on Thursday, April 30th. Piper Sandler reaffirmed a “neutral” rating and issued a $254.00 target price (up from $182.00) on shares of Humana in a report on Wednesday, May 13th. Truist Financial increased their target price on Humana from $320.00 to $415.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Finally, The Goldman Sachs Group lifted their price target on Humana from $158.00 to $195.00 and gave the company a “sell” rating in a research note on Thursday, April 30th. Two investment analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating, fifteen have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $327.17.

Humana Price Performance

Shares of NYSE:HUM opened at $388.09 on Wednesday. The firm has a market cap of $46.59 billion, a PE ratio of 41.51, a price-to-earnings-growth ratio of 2.07 and a beta of 0.71. The firm’s fifty day moving average is $367.16 and its 200-day moving average is $266.44. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. Humana Inc. has a 52 week low of $163.11 and a 52 week high of $428.88.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The business had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.Humana’s quarterly revenue was up 23.5% on a year-over-year basis. During the same period in the prior year, the business posted $11.58 earnings per share. Sell-side analysts predict that Humana Inc. will post 9.46 earnings per share for the current year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.